The quick read
Latest quote·Oct 13
Net selling: insiders sold $221K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNet selling: insiders sold $221K and bought $0 of AGNC stock on the open market in the 90 days to Oct 18, 2026, according to SEC Form 4 filings. The largest was Bell, Bernice (EVP, CFO), who sold $221K. The latest filing was on Aug 21, 2026.
None. No member of Congress disclosed a AGNC trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 18, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net selling.
Sells/Trims (3)
Millennium
$48.0M
trimmed
Qube Research
$37.1M
trimmed
Susquehanna
$19.8M
trimmed
No tracked top-trader positions in AGNC right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Jul 20, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.38 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 20, 2026 | $0.40 / $0.38Alpha Vantage | +5.26% beat | Unavailable | Unavailable |
| Mar 31, 2026 | Apr 20, 2026 | -$0.17 / $0.12Alpha Vantage | -$0.29 miss | Unavailable | Unavailable |
| Dec 31, 2025 | Jan 26, 2026 | $0.83 / $0.45Alpha Vantage | +84.44% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 20, 2025 | $0.35 / $0.39Alpha Vantage | -10.26% miss | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 21, 2025 | $0.38 / $0.41Alpha Vantage | -7.32% miss | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 21, 2025 | $0.44 / $0.41Alpha Vantage | +7.32% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Jan 27, 2025 | $0.10 / $0.41Alpha Vantage | -75.61% miss | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 21, 2024 | $0.39 / $0.47Alpha Vantage | -17.02% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 16, 2026
EPS expected
$0.36 to $0.40
Revenue expected
6 analysts
Last 30 days
Analysts raising estimates
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $779.0M | $1.26B | $1.05B | $684.0M |
| Cost of what it sold | $20.0M | $30.0M | $731.0M | $19.0M |
| Gross profit | $779.0M | $1.26B | $319.0M | -$19.0M |
| What it spent | ||||
| Sales and admin | $20.0M | $30.0M | $34.0M | $19.0M |
| Other operating costs | -$795.0M | -$464.0M | — | $11.0M |
| Total operating expenses | -$775.0M | -$434.0M | $34.0M | $30.0M |
| What was left | ||||
| Operating profit | $1.55B | $1.69B | $285.0M | -$49.0M |
| Interest on debt | $755.0M | $738.0M | $731.0M | $709.0M |
| Profit before tax | $806.0M | $954.0M | -$148.0M | $610.0M |
| Net profit | $806.0M | $954.0M | -$148.0M | $610.0M |
| EBITDA | $1.69B | $1.69B | $583.0M | -$49.0M |
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace